Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Portfolio Pulse from Avi Kapoor
Wall Street's most accurate analysts have provided updates on three high-dividend yielding health care stocks: Johnson & Johnson (JNJ), Patterson Companies (PDCO), and Gilead Sciences (GILD). JNJ is in talks to acquire Shockwave Medical, Inc (SWAV). PDCO approved a $500 million stock buyback and declared a quarterly dividend. GILD announced the completion of the acquisition of CymaBay.
March 27, 2024 | 12:13 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Gilead Sciences completed the acquisition of CymaBay, with analysts adjusting price targets downwards.
The completion of the CymaBay acquisition is a positive development, but analyst price target adjustments suggest caution.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Johnson & Johnson is in talks to acquire Shockwave Medical, Inc, with mixed analyst ratings and slight adjustments in price targets.
Acquisition talks with SWAV could lead to positive market sentiment towards JNJ, despite mixed analyst ratings.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Patterson Companies approved a $500 million stock buyback and declared a quarterly dividend, with analysts maintaining cautious ratings.
The stock buyback and dividend declaration could boost investor confidence, despite cautious analyst ratings.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 85
POSITIVE IMPACT
Shockwave Medical, Inc is in talks to be acquired by Johnson & Johnson, which could significantly impact its market position.
Being a target for acquisition by JNJ could lead to a positive reevaluation of SWAV's stock, given JNJ's market influence.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 95